BioSpace News Archive

Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the July 11th life sciences conference are now available for on-demand viewing at VirtualInvestorConferences.com.

The versatile and compact system offers the power and simplicity to support more patients in more places

Soom, a pioneer in utilizing barcode and knowledge graph technologies to bridge information gaps between data sources and physical products, has introduced SoomSafety, an iOS mobile app that allows users to scan a medical device and receive instructions for use, safety and recall information directly from the device manufacturer and U.S. Food and Drug Administration (FDA).

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Columbia Care Inc. (NEO: CCHW; OTCQX: COLXF), one of the largest fully-integrated operators in the global medical cannabis industry with licenses in 15 jurisdictions across the US and the EU, has qualified to trade on the OTCQX® Best Market.

Ligand’s CEO John Higgins, President and COO Matt Foehr, and Executive Vice President and CFO Matt Korenberg will host the conference call.

He joins MDIC following his most recent tenure leading the clinical affairs and regulatory programs for Cryterion Medical, makers of cryoablation platform for atrial fibrillation that was acquired last year by Boston Scientific.

Americord was one of the first family cord blood banks to store placental tissue and now offers this exciting product, which stores live amniotic membrane (AM), a first for the industry.

Novacap sees tremendous growth potential in Spectrum and will work with management to strengthen Spectrum’s position as a market leader in Home Care in Ontario.

A global data analytics and advisory firm, Quantzig, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of their latest patient journey analytics engagement for a leading biopharma client.

NovaBay® Pharmaceuticals, Inc., a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that President and CEO Justin Hall has issued the following letter to stockholders: